O
Ochre Bio is a biotechnology company developing RNA therapies for chronic liver diseases. Using a combination of genomic deep phenotyping, precision RNA medicine, and testing in live human donor livers, Ochre is developing therapies for important liver health challenges, from increasing donor liver supply to reducing cirrhosis complications. To learn more, please visit www.ochre-bio.com.
Investor insights
Funding rounds participated in
$30M sweet spot round size
Investor type
Privately Held
Basic info
Industry
Biotechnology Research
Sectors
Biotechnology Research
Date founded
2019
Funding rounds raised
Total raised
$30M
from 2 investors over 1 rounds
O
Ochre Bio raised $30M on November 10, 2022
Investors: Khosla Ventures and + 9 Other investors